Skip to content
healthcare.dev

Tizanidine

NDC 70518-1598, Tizanidine, tablet, from REMEDYREPACK INC..

Product NDC
70518-1598
Status
Listed
Labeler
REMEDYREPACK INC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091283
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70518-1598 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TIZANIDINE HYDROCHLORIDE4 mg/1

Pharmacologic classes

Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]

Package NDCNDC-11Package
70518-1598-17051815980160 TABLET in 1 BOTTLE, PLASTIC (70518-1598-1)
70518-1598-37051815980330 TABLET in 1 BOTTLE, PLASTIC (70518-1598-3)
70518-1598-47051815980490 TABLET in 1 BOTTLE, PLASTIC (70518-1598-4)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/b14bd166-9f53-4f2e-be05-c447af04ef69

Use it

Look up 70518-1598 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70518-1598 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70518-1598. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.